Bullboard Post History

by Riverfolk

Order by:

V.ARCH	RE:Arch Biopartners - Where is the disconnect? From an investing point of view it is great that Management is not paying to... May 20, 2020
V.ARCH	Covid19 - Reuters - Arch Awareness https://www.google.ca/amp/s/mobile.reuters.com/article/amp/idUSASA00QXG May 19, 2020
V.ARCH	RE:COVID 19 -ARCH PHASE 2 HUMAN TRIAL EXPANDED Phase 2 Human trial now testing LUNG, LIVER and KIDNEY. As an investor this... May 19, 2020
V.ARCH	Covid19 - Treatment - 83% Survival Rate I have received a lot of interest from my post last night. The information I... May 15, 2020
V.ARCH	RE:Clarification - Mouse DNA and Human DNA Further, to determine whether peptide binding to DPEP1 was conserved across... May 15, 2020
V.ARCH	Covid19 - Metablok - <83% Survival Rate Results found that an increase in overall survival from 0 to 57% when the... May 15, 2020
V.ARCH	Covid19 - Discovery could help prevent deaths http://www.ucalgary.ca/news/ucalgary-researchers-find-way-stop-lung-damage... May 15, 2020
V.ARCH	Covid19 - Another reason to invest in Arch https://www.google.ca/amp/s/mobile.reuters.com/article/amp/idUSKBN22Q0U7... May 14, 2020
V.ARCH	RE:Covid -19 Damage to Kidneys Thank you for this post, do you have the link? Metablok treating multiple... May 14, 2020
V.ARCH	RE:Clarification - Mouse DNA and Human DNA Much of our current understanding of the normal functioning of the lung and... May 10, 2020
V.ARCH	RE:Success in trials using mice for human therapies Comparative medicine is built on the ability to use information from one... May 10, 2020
V.ARCH	COVID 19 - ARCH BIOPARTNERS - MY DUE DILIGENCE When looking at bio stocks these days, I see so many pump and dump plays with... May 9, 2020
V.ARCH	The show has only just begun It is understandable for those who have been in this play from .30 to take... May 8, 2020
V.ARCH	Initial selling has ended Now it's time for the lift to begin May 8, 2020
V.ARCH	Soon to be an American story! OTC As a result of clinical interest to support the Phase II trial in the United... May 8, 2020
V.ARCH	Health Canada approval 58,000,000 shares outstanding 0 warrants 55% insider held ... May 8, 2020
V.ARCH	Arch taking aim at respiratory distress https://www.biocentury.com/article/305009 May 7, 2020
V.ARCH	RE:Health Canada Approval Awareness will definitely grow if Health Canada does not object to a phase 2... May 6, 2020
V.ARCH	Covid 19 - Treatment - Metablok {^youtubevideo\|(width)425\|(height)264\|(rel)False\|(url)https://www.youtube.com... May 4, 2020
V.ARCH	TD - Arch Biopartners Most Recent Target 1.90 - 2.05 We are one high volume day away from achieving this target price set by Td... May 4, 2020

Become a member today, It's free!

Bullboard Post History

by Riverfolk

RE:Arch Biopartners - Where is the disconnect?

Covid19 - Reuters - Arch Awareness

RE:COVID 19 -ARCH PHASE 2 HUMAN TRIAL EXPANDED

Covid19 - Treatment - 83% Survival Rate

RE:Clarification - Mouse DNA and Human DNA

Covid19 - Metablok - <83% Survival Rate

Covid19 - Discovery could help prevent deaths

Covid19 - Another reason to invest in Arch

RE:Covid -19 Damage to Kidneys

RE:Clarification - Mouse DNA and Human DNA

RE:Success in trials using mice for human therapies

COVID 19 - ARCH BIOPARTNERS - MY DUE DILIGENCE

The show has only just begun

Initial selling has ended

Soon to be an American story! OTC

Health Canada approval

Arch taking aim at respiratory distress

RE:Health Canada Approval

Covid 19 - Treatment - Metablok

TD - Arch Biopartners Most Recent Target 1.90 - 2.05

Featured News Links

Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments

Featured Company

Viva Gold Corp. V.VAU

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Riverfolk

Featured News Links

Featured Company